-
11-09-2021, 08:34 AM
#19681
Maybe this happened
Brrr Brrr at PEB
"Hullo, ASX here"
"Can I help you"
" Yes that document for a cap raise attached to the Listing application has a closing date of September 10th."
"OMG how did that happen?"
"No idea, but as PEB is not even listed yet over here we cant see a cap raise being too successful by Friday.
"OK, we will have to reapply as that document is incorrect"
Market advised " document is incorrect"
What's " porkies" about that?
-
11-09-2021, 12:09 PM
#19682
Originally Posted by Minerbarejet
Maybe this happened ….
"No idea, but as PEB is not even listed yet over here we cant see a cap raise being too successful by Friday.
"OK, we will have to reapply as that document is incorrect"
Market advised " document is incorrect"
What's " porkies" about that?
Flaw with that scenario is that a CR is always done prior to a listing. Not the other way round.
Last edited by Balance; 11-09-2021 at 12:28 PM.
-
11-09-2021, 12:48 PM
#19683
Originally Posted by Balance
Flaw with that scenario is that a CR is always done prior to a listing. Not the other way round.
The only information we had to work on was a listing being applied for by the end of the month. Hopefully.
Regardless, there was not enough time to do a CR by the 10th.
-
11-09-2021, 12:54 PM
#19684
Originally Posted by Minerbarejet
The only information we had to work on was a listing being applied for by the end of the month. Hopefully.
Regardless, there was not enough time to do a CR by the 10th.
Not true.
Companies do CR placements all the time within 2 or 3 workings days.
Have a look at PX1 and you will see exactly how it happens.
Last edited by Balance; 11-09-2021 at 01:17 PM.
-
11-09-2021, 01:23 PM
#19685
Originally Posted by Balance
Not true.
Companies do CR placements all the time within 2 or 3 workings days.
Have a look at PX1 and you will see exactly how it happens.
OK I stand corrected.
-
11-09-2021, 02:27 PM
#19686
Member
This screw up will disapear very quickly whether they go for a CR or not if they can show significant growth in lab test output, a new group association like Kaiser, adoption in Australia or somewhere else.
-
11-09-2021, 02:50 PM
#19687
Originally Posted by Harrie
This screw up will disapear very quickly whether they go for a CR or not if they can show significant growth in lab test output, a new group association like Kaiser, adoption in Australia or somewhere else.
Or perhaps even show a payment for tests done for CMS prior to acceptance.
We are not running a US Medical Subsidy Scheme here.
-
11-09-2021, 11:29 PM
#19688
Member
They have the proof, they have affirmations by the AUA, they have a methodology/ IP that no one in their right mind would want to spend millions on trying to beat, they have a sales force in the USA, so they better have some very good reason to want to tap existing and new shareholders for $70 mio. The only reason I can think of, and would like to think of, is a massive uptake in demand
-
12-09-2021, 08:20 AM
#19689
Originally Posted by Harrie
They have the proof, they have affirmations by the AUA, they have a methodology/ IP that no one in their right mind would want to spend millions on trying to beat, they have a sales force in the USA, so they better have some very good reason to want to tap existing and new shareholders for $70 mio. The only reason I can think of, and would like to think of, is a massive uptake in demand
If they have exhausted the Hershey test facility of 250,000 tests per year and need more capacity then that would be a stunning achievement and probably unlikely. Fast tracking the trials and acceptance for other types of cancer as miner suggests would be a good use of the additional spondooli and shareholders would support that.
-
12-09-2021, 10:02 AM
#19690
Member
Originally Posted by Brain
If they have exhausted the Hershey test facility of 250,000 tests per year and need more capacity then that would be a stunning achievement and probably unlikely. Fast tracking the trials and acceptance for other types of cancer as miner suggests would be a good use of the additional spondooli and shareholders would support that.
I would imagine PEB will need a lab in Singapore since it is considered as a medical hub for its neighbor countries. They might also need a lab in a smaller scale for the Australian market. If PEB had gained some tractions in both countries, they might need to build the labs in early days just like what they did ten years ago in US. Speculating in a good way :-)
Last edited by zs_cecil; 12-09-2021 at 10:06 AM.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks